The optimized conjugates exhibited an unprecedented signal-to-background ratio of 300 or more in IHC, thereby allowing high-contrast imaging of HER2 overexpression on BC cell membranes without optical background interference 246. The gene discussed is ERBB2; the disease is breast cancer.